Categories AlphaGraphs, Earnings, Health Care
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues.
Total revenue declined 7% year-over-year to $2.30 billion in the March quarter. For the full year of 2024, the company expects revenues to decline in the low-to-mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.
Net income attributable to Biogen was $393.4 million or $2.70 per share in Q1, compared to $387.9 million or $2.67 per share in the prior-year period. Adjusted earnings moved up 8% annually to $3.67 per share in the first quarter.
Prior Performance
Most Popular
Key takeaways from Micron’s (MU) first-quarter 2026 results
Micron Technology Inc. (NASDAQ: MU) has reported blockbuster first-quarter results, comfortably beating estimates as strength in data center demand pushed key operating metrics to record levels. Management is now focused
Lennar (LEN) continues to battle a stubbornly difficult housing market
Shares of Lennar Corporation (NYSE: LEN) were down 2% on Thursday. The stock has dropped 17% over the past three months. The homebuilder saw its revenues and profits decline in
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
